Sun Pharmaceutical Industries Ltd.

The company's total revenue for the quarter ended June 2026 saw a slight change in the total revenue, having registered a total revenue of Rs. 57411.30 millions.A comparatively good net profit growth of 49.67% to Rs. 11151.40 millions was reported for the quarter ended June 2026 compared to Rs. 7450.60 millions of previous same quarter.Operating profit surged to 21043.80 millions from the corresponding previous quarter of 20132.40 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	57411.30	55948.80	2.61	57411.30	55948.80	2.61	207546.40	229774.00	-9.67
Other Income	1401.70	1037.10	35.16	1401.70	1037.10	35.16	4193.30	3791.40	10.60
PBIDT	21043.80	20132.40	4.53	21043.80	20132.40	4.53	66000.20	72168.40	-8.55
Interest	2784.80	2384.20	16.80	2784.80	2384.20	16.80	9478.40	9538.90	-0.63
PBDT	17943.70	14871.80	20.66	17943.70	14871.80	20.66	51058.40	62629.50	-18.48
Depreciation	3079.20	3109.20	-0.96	3079.20	3109.20	-0.96	13117.20	12867.40	1.94
PBT	14864.50	11762.60	26.37	14864.50	11762.60	26.37	37941.20	49762.10	-23.75
TAX	3713.10	4312.00	-13.89	3713.10	4312.00	-13.89	11707.00	7481.30	56.48
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	11151.40	7450.60	49.67	11151.40	7450.60	49.67	26234.20	42280.80	-37.95
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	36.65	35.98	1.86	36.65	35.98	1.86	31.80	31.41	1.25